https://mohnfoundation.no/en/stemcelltherapy/

Stem Cell Therapy

Bone transplantations are carried out more than 1 million times per year in Europe, and the new bone tissue is often grown from the patient’s own stem cells. But there are areas of the body where stem cell treatment has not yet been successful. The jawbone at the very back of the mouth is such an area, as the mouth moves a lot, there is poor blood flow in the jawbone and the mouth is full of bacteria.

If you lose teeth in adulthood due to, for example, diseases or injuries, dental implants can replace your own teeth, but the implants need enough jawbone to remain completely fixed. For patients with too little bone tissue in the jaw, this can lead to social stigmatization due to missing teeth. Until now, bone tissue had to be transplanted from other places in the body, but the procedure is complicated and known to cause pain for the patients.

Associate professor and dentist Cecilie Gjerde from the Department of Clinical Dentistry at UiB has already managed to help eleven patients with jawbone reconstruction in a pilot trial: She and the research team used the body’s own stem cells and bicalcium phosphate as building material, so that the cells had something to grow on.

To further test the method in a larger clinical study, the Trond Mohn Foundation in collaboration with UiB has financed a 4-year research project. Gjerde works together with Professor Kamal Mustafa from the same department, who is one of Europe’s leading experts in bone tissue reconstruction.

The researchers have worked in many different European research consortia and can draw on this collaboration, which will benefit patients in Norway.

The research group

Research production and innovation activity

The Tissue Engineering Group at IKO under the leadership of Professor Kamal Mustafa and Associate Professor Cecilie Gjerde is producing innovative research in the field of regenerative medicine and translational research. The main focus of the research group is the development of translational approaches for regenerative therapies using mesenchymal stem cells (MSC). The group has contributed significantly to 4 large EU collaborative projects, initiated during the recent years (VascuBone, FP7 project no. 242175, REBORNE, FP7 project no. 241879, H2020 Maxibone, project no. 779322 and H2020 BonFix, project no. 952150).

The present project funded by Trond Mohn Foundation (TMS) and the clinical studies performed by the group, propose innovative alternatives to conventional treatment modalities by using the concept of tissue engineering in which bicalcium phosphate granules produced by Biomatlante®, France are used as scaffolds to deliver MSC. Our data showed that stem cells combined with calcium phosphate scaffolds induce the formation of new bone. Interestingly, the data clearly demonstrated formation of the new bone with good quality and quantity enabling us to install dental implants produced by Dentsply, Sweden (Fig.1). Furthermore, osteogenic differentiation of mesenchymal stem cells can be induced solely by mechanical stimulation in a closed bioreactor system, which was mediated by enhanced cellular contractility under medium flow.

The process of regeneration of bone – from cells to new teeth.

The Trond Mohn Foundation would like to congratulate the Tissue Engineering Research Group at UiB on the recent awards and funding.

The industrial partners Biomatlante®, France and Dentsply, Sweden provided and donated the bone substitute materials (BCP granules) and the dental implants respectively.

Facts about the project:

Funding period

2018-2023

Reconstruction of mandibular bone using stem cells and biomedical engineering approaches

TMS funding 8 MNOK

Total budget 16.7 MNOK

Project web page

Mustafagjerde Foto Kim E Andreaasen
mustafagjerde_foto_kim e andreaasen
Cecilie Gjerde og Kamal Mustafa, UiB Foto Kim E. Andreassen